Research Papers: Neuroscience:
Nitrobenzylthioinosine mimics adenosine to attenuate the epileptiform discharge of hippocampal neurons from epileptic rats
Metrics: PDF 1227 views | HTML 1485 views | ?
Hao Huang1,*, Jing Wang2,*, Jun Zhang1, Zhong Luo1, Dongxu Li1, Xiaowei Qiu1, Yan Peng1, Zhongxiang Xu1, Ping Xu1 and Zucai Xu1
1 Department of Neurology, Affiliated Hospital of Zunyi Medical College, Zunyi, Guizhou, China
2 Department of Prevention and Health Care, Affiliated Hospital of Zunyi Medical College, Zunyi, Guizhou, China
﹡ These authors have equal contribution to this work
Ping Xu, email:
Zucai Xu, email:
Keywords: epilepsy, nitrobenzylthioinosine, adenosine, adenosine A1 receptor, Neuroscience
Received: January 06, 2017 Accepted: March 02, 2017 Published: March 08, 2017
Nitrobenzylthioinosine (NBTI), a specific inhibitor of type 1 equilibrative nucleoside transporter, could regulate the extracellular adenosine concentration and have protective roles in seizures. However, the protection mechanism of NBTI in seizures remains poorly understood. Here, the expression pattern and subcellular distribution of adenosine A1 receptor were detected by Western blot analysis and double-labeling immunofluorescence staining in Lithium Chloride-Pilocarpine induced epileptic rat model. At 24 h after pilocarpine induced rat seizures, hippocampal slices were prepared and the evoked excitatory postsynaptic currents (eEPSCs) amplitude of pyramidal neurons in hippocampus CA1 region was recorded using whole-cell patch clamp. In vivo, compared to control group, Western blotting analysis showed that the expression of adenosine A1 receptor protein was increased at 24 h and 72 h after seizure, didn’t change at 0 min and 1 w, and decreased at 2 w. Double-label immunofluorescence revealed that adenosine A1 receptor was mainly expressed in the membrane and cytoplasm of neurons. In Vitro, adenosine decreased the eEPSCs amplitude of pyramidal neurons in hippocampus CA1 region, NBTI also had the same effect. Meantime, NBTI could further inhibit eEPSCs amplitude on the basis of lower concentration adenosine (50µM), and adenosine A1 receptor inhibitor DPCPX partially reversed this effect. Taken together, we confirmed that the expression of adenosine A1 receptor protein was increased in the early seizures and decreased in the late seizures. At the same time, NBTI mimics adenosine to attenuate the epileptiform discharge through adenosine A1 receptor, which might provide a novel therapeutic approach toward the control of epilepsy.
All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 3.0 License.